SLC25A16: A Potential Drug Target for Brain and Disease (G8034)

Target Name: SLC25A16

NCBI ID: G8034

SLC25A16

SLC25A16: A Potential Drug Target for Brain and Disease

SLC25A16 (GDC-HUMAN) is a protein that is expressed in various tissues of the human body, including the brain, heart, and liver. It is a member of the selective nuclear transport (SNT) family, which involves the transport of specific nucleic acids across the nuclear membrane.

SLC25A16 is a 25 kilobase (kb) protein that is expressed in the brain, heart, and liver. It is localized to the nuclear envelope, which is the outermost layer of the nuclear membrane. SLC25A16 is involved in the transport of a variety of nucleic acids across the nuclear membrane, including mRNA, tRNA, and rRNA.

SLC25A16 has been shown to play a role in the regulation of various cellular processes, including cell growth, apoptosis (programmed cell death), and inflammation. It has also been shown to be involved in the development and progression of certain diseases, such as neurodegenerative diseases and autoimmune diseases.

One of the most promising aspects of SLC25A16 is its potential as a drug target. By targeting SLC25A16 with small molecules or other therapeutic agents, researchers may be able to interfere with its function and treat a variety of diseases.

SLC25A16 has been shown to play a role in the regulation of cellular processes that are important for brain function. For example, studies have shown that SLC25A16 is involved in the transport of mRNA across the nuclear membrane, which is important for the production of new proteins that are critical for brain development and function.

In addition, SLC25A16 has also been shown to play a role in the regulation of cellular processes that are important for the survival and proliferation of neural cells. Studies have shown that SLC25A16 is involved in the transport of tRNA across the nuclear membrane, which is important for the delivery of essential nutrients to neural cells.

SLC25A16 has also been shown to play a role in the regulation of cellular processes that are important for the development and progression of certain diseases. For example, studies have shown that SLC25A16 is involved in the transport of rRNA across the nuclear membrane, which is important for the production of proteins that are critical for the development and progression of neurodegenerative diseases.

In conclusion, SLC25A16 is a protein that is expressed in various tissues of the human body, including the brain, heart, and liver. It is involved in the transport of various nucleic acids across the nuclear membrane, which plays a role in the regulation of various cellular processes. SLC25A16 is also potential as a drug target, due to its involvement in the regulation of cellular processes that are important for brain function and the development and progression of certain diseases.

Protein Name: Solute Carrier Family 25 Member 16

Functions: Required for the accumulation of coenzyme A in the mitochondrial matrix

The "SLC25A16 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SLC25A16 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets